Keyword: "decision aid"

39 items were found with the keyword "decision aid".

  • LowSalt4Life

    PI: Mike Dorsch , Scott Hummel MD MS

    High dietary sodium intake is linked to incident hypertension, stroke, heart failure and kidney disease. U.S. federal guidelines advocate daily sodium intake of less than 2,300 milligrams (mg) with further reduction to 1,500 mg in persons who are 51 and older and those of any age who are African American and/or have hypertension, diabetes, or chronic kidney disease. The estimated average sodium intake for Americans is 3,400 mg per day. In recent years, consumption of pre-processed and restaurant foods has substantially increased, and more than 75% of sodium in the average U.S. diet now comes from these sources. The important gap is that most patients prescribed a low sodium diet either do not understand or have information about the sodium content of the foods they eat, and current IT approaches to reduce sodium intake focus solely on counting the amount of dietary sodium eaten. Therefore, there is a critical need to develop technologies that provide just-in-time information about low sodium choices in both grocery stores and restaurants with an overall goal to improve the ability to reduce dietary sodium intake. LowSalt4Life is an app designed to provide education, assistance, and support to people who are trying to reduce their sodium intake. It includes actionable push messages to promote adherence to a low sodium diet, and was developed using information derived from focus groups. The goal is to demonstrate the effectiveness of the mobile application in reducing sodium intake in participants with hypertension.   (08/01/2016 - 08/01/2019)

  • Increasing HPV vaccine coverage among young adult gay and bisexual men

    New

    PI: Annie-Laurie McRee, DrPH , Paul L. Reiter, PhD, MPH

    The goal of the study is to collect pilot data on whether a mobile/web-based intervention can increase HPV vaccine coverage among young adult gay and bisexual men. (02/01/2016 - 06/01/2017)

  • Breast Cancer Ally

    New

    PI: Michael Sabel, MD, FACS

    Breast Cancer Ally is an iPhone app developed in partnership with University of Michigan breast cancer specialists. It provides information about breast cancer and helps patients at the University of Michigan Comprehensive Cancer Center manage their symptoms. Breast Cancer Ally helps patients through every stage of treatment, from the initial diagnosis, through surgery, chemotherapy, radiation therapy, and anti-estrogen therapy.More information can be found at the University of Michigan Comprehensive Cancer Center site. (04/01/2014 - present)

    Related Media:

  • Improving Patient Decisions about Bariatric Surgery

    New

    PI: Nancy J. Birkmeyer, PhD , Amir A. Ghaferi, MD, MS

    Obesity is increasingly considered among the most important public health problems of our times. Bariatric surgery is arguably the only treatment that has proven effective in producing long-term weight loss for patients with morbid obesity. Bariatric surgery also results in resolution of obesity related co-morbid conditions, improvements in quality of life, and increased survival. There are currently four different bariatric surgical procedures in use: adjustable gastric banding, gastric bypass, sleeve gastrectomy, and duodenal switch. Bariatric surgery is considered a highly preference sensitive medical issue. Existing decision aids in bariatric surgery are limited in that they provide information about the average comparative risks and benefits of the treatment options, but do not provide customized estimates of the risks and benefits of the different procedures for individual patients. As a result of these draw-backs, decision aids are not frequently used in making treatment decisions in bariatric surgery. Our proposal is highly innovative in that our decision support tool integrates data from a large clinical registry with individual patient data to provide patients with real-time, customized, accurate information regarding the risks and benefits of the treatment options to better inform decision making. This tool will be continuously updated to ensure that the data on risks and benefits that it provides are accurate and current. Our tool also provides information about other attributes of the treatment options that bariatric surgery patients and other relevant stakeholders feel are important for patients to consider in deciding whether and what type of bariatric surgery to have. The proposed research promotes shared medical decision making for patients who are considering bariatric surgery for the treatment of morbid obesity. If our intervention proves effective, it will result in improved decision quality and outcomes of care for patients. It may also result in improved efficiency of care to the extent that it serves to augment or guide communication between the patient and physician to promote shared medical decision-making. (09/01/2013 - 08/31/2016)

  • Dizztinct - Dizziness Treatment for Patients

    New

    PI: Kevin A. Kerber, MD

    Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder and causes disabling symptoms. BPPV produces a sensation of spinning called vertigo that is both paroxysmal and positional, meaning it occurs suddenly and with a change in head position. The disorder stems from free-floating particles that enter a semi-circular canal ("canaliths") of the inner ear. BPPV is diagnosed using a simple and reliable positional test, the Dix-Hallpike test (DHT). The treatment, the Canalith Repositioning Maneuver (CRM), is performed in minutes at the bedside. With these processes, patients can be readily identified and treated at the bedside, quickly and without expensive tests. Yet, these guideline-supported evidence-based practices are substantially underutilized. This project aims to implement these processes in a real world care setting, through a multi-faceted implementation strategy. The project has the potential to simultaneously improve patient outcomes and healthcare efficiencies. (08/01/2013 - 07/31/2017)

  • Cultural tailoring of educational materials to minimize disparities in HPV vaccinations

    New

    PI: Amanda F. Dempsey, MD, PhD, MPH

    This project is designed to test the effectiveness of cultural and individual tailoring on decisions about HPV vaccines. (01/01/2013 - 12/31/2015)

    Related Media:

  • Individualized CANcer Care (I Can Care): Project 2

    PI: Jennifer J. Griggs, MD, MPH

    It's a challenge to know how much it helps to add systemic therapy (e.g., chemotherapy) to a woman's regimen of breast cancer care. For a woman with a favorable prognosis, chemotherapy may add relatively little benefit - but put her through a great deal of difficulty. Genomic testing can help understand who may benefit from chemotherapy and how it impacts the risk of recurrence. (07/01/2012 - 06/30/2017)

  • Individualized CANcer Care (I Can Care): Project 1

    PI: Reshma Jagsi, MD, DPhil

    Making individualized choices about surgery and radiation is challenging for patients and clinicians. This project is looking at ways to help make these choices with testing. Evaluative tests can help inform who might benefit from certain treatments and how much. (07/01/2012 - 06/30/2017)

  • I Can Decide

    PI: Sarah T. Hawley, PhD, MPH

    Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoreginal and systemic treatment. Currently many of these decisions do not meet the definition of a high quality decision, defined as one that is both informed (based on an accurate understanding of the treatment risks and benefits) and preference-concordant (consistent with the patient's underlying preferences). I Can Decide evaluates the impact of an innovative decision tool on locoregional and systemic therapy decision making for newly diagnosed breast cancer patients. (07/01/2012 - 08/31/2017)

    Related Media:

  • Communications & Dissemination Core

    PI: Steven J. Katz, MD, MPH , Lawrence C. An, MD

    The goal of this program is to help clinicians and their patients address the challenges of individualizing the treatment of breast cancer. The Communications and Dissemination Core's primary goal is to translate key research findings into personally relevant messages for patients and clinicians. We do this by creating 1) an interactive online tool to help patients improve breast cancer treatment decision making, and 2) an interactive website to education clinicians about breast cancer practice norms, patients' experiences, and effective communication strategies. (07/01/2012 - 06/30/2017)

  • DATES

    PI: Masahito Jimbo, MD, PhD, MPH

    DATES (Decision Aid to Technologically Enhance Shared Decision Making) is an interactive decision aid website for colorectal cancer, designed to be used prior to a clinic visit to clarify each patient's preferences and promote shared decision-making. The website uses a unique interactive Preference Elicitation Tool, which helps patients determine the colorectal cancer screening test option that best matches their preferences. (04/01/2011 - 03/31/2015)

  • Making the Choice - VA

    PI: Angela Fagerlin, PhD

    A current priority for VA research is "Healthcare Informatics to Improve Veteran Care Healthcare." This priority area recognizes the critical importance of developing effective technological tools for Veterans to improve their understanding of and capacity to be actively involved in shared decision making about key health issues. Making The Choice - VA develops new materials specifically for VA patients who have prostate cancer. The tool helps in shared and informed decision-making related to prostate cancer treatment options and outcomes. (01/01/2011 - 09/30/2011)

  • VA Cardiovascular Tool

    PI: Rodney A. Hayward, MD

    It is critically important to develop effective technological tools for Veterans to improve their understanding of and capacity to be actively involved in shared decision making about key health issues. It is also critical to make sure both the patients´┐Ż and the clinicians´┐Ż decisions are informed decisions. (01/01/2011 - 09/30/2011)

  • iDecide/iDecido

    PI: M. E. Michele Heisler, MD, MPA

    Successful diabetes management is dependent on the patient - provider partnership. However, a full discussion of potential benefits, harms, costs, and burdens associated with each medication option is often too much for a brief clinic visit. This project uses AHRQ-developed consumer guides as inspiration for a tailored program that assists with this decision-making. The intervention is delivered on iPads by Community Health Workers in participant homes and is available in both English and Spanish. (09/30/2010 - 09/29/2013)

    Related Media:

  • Take the Pledge: Organ Donation

    PI: Ann Andrews, MPH

    Take the Pledge rigorously evaluates the efficacy of a novel intervention in alumni (or graduate) chapters of African American sororities and fraternities in Michigan to increase organ and tissue donation, as assessed by registration in the Michigan Organ Donor Registry. (09/01/2010 - 08/31/2012)

  • Me First

    PI: Vanessa K Dalton, MD, MPH , Ruth C. Carlos, MD

    MeFirst aims to develop and refine a tailored risk communication intervention to improve HPV vaccination uptake in young adult women ages 18-26 when administered during a teachable moment. The teachable moment is a spontaneously occurring health event that serves as a natural educational gateway. The potential effects of this intervention on HPV vaccine utilization in a hard-to-reach age group enhances system-based interventions that can be more broadly applied or generalized to other health interventions targeted to young adults or other health settings. (07/01/2010 - 06/30/2011)

  • Liver Quality Decision Aid

    PI: Michael L. Volk, MD, MSc, AGAF

    Organs available for transplantation are of varying quality. Patients awaiting transplant need to balance the risk of taking a lower quality organ to keep them alive versus the risk of dying while waiting for a transplant. This decision aid includes an exercise to help people decide the level of quality they might be willing to accept, given their specific risk of death in the next 3 months. (02/01/2010 - 12/31/2014)

  • Breast Cancer Genetics Usability Test

    PI: J. Scott Roberts, PhD

    The purpose of this project is to develop and test a web-delivered, tailored decision aid for women at risk for breast and ovarian cancer. Existing educational materials are refined then offered in an interactive website featuring greater personalization of risk information, using validated risk communication techniques in a patient-friendly Web-based application.Such technologies are needed to expand the reach and improve the cost- effectiveness of breast cancer genetic services and are part of a growing movement within clinical care to provide validated patient decision aids. (03/01/2009 - 02/28/2010)

  • Discussing the Choice

    PI: Angela Fagerlin, PhD , Peter A. Ubel, MD

    DVDs demonstrate to patients some of the issues that might arise during their prostate cancer diagnosis visit that may prevent them from sharing in the decision of what treatment to choose. The DVDs also provide solutions that would allow for patients' participation in the treatment decision making process. (09/01/2008 - 08/31/2013)

    Related Media:

  • CECCR2 - Center of Excellence In Cancer Communications Research II

    PI: Victor J. Strecher, PhD, MPH

    The purpose of the University of Michigan Center of Excellence in Cancer Communications Research (CECCR) is to develop an efficient, theory-driven model for generating tailored health behavior interventions for many health behaviors and socio-demographic populations. (09/01/2008 - 08/31/2013)

  • Decider Guider - VA

    PI: Sarah T. Hawley, PhD, MPH

    Colorectal cancer (CRC) is the third most prevalent cancer in the U.S. Dept. of Veteran Affairs (VA) and the second most costly cancer. This study aims to increase the number of VA patients who complete a CRC screening. It integrates an innovative and flexible preference elicitation methodology, conjoint analysis, into a decision tool to help VA patients clarify their preferences for characteristics of CRC screening tests. (07/01/2008 - 03/31/2012)

  • Decider Guider - Primary Care

    PI: Sarah T. Hawley, PhD, MPH

    This study aims to increase the number of insured, primary care patients who complete a colorectal cancer (CRC) screening. This study integrates an innovative preference elicitation methodology, conjoint analysis, into a decision tool to help primary care patients clarify their preferences for CRC screening tests. The two sites participating in this study also allow for a more racially/ethnically diverse audience than other Decider Guider studies. (06/09/2008 - 04/30/2012)

  • Breast Cancer Patient Educational Tool

    PI: Sarah T. Hawley, PhD, MPH

    For the past decade there has been debate around whether mastectomy or breast conserving surgery (BCS) with radiation is the "best" treatment for early stage breast cancer. The goal of this study is to develop and pilot test an interactive computer-based decision tool for improving patient knowledge about breast cancer treatment, and help elicit patients' preferences for treatment characteristics. (09/20/2007 - 08/31/2009)

  • Improving Risk Communication through Tailored Testimonials

    PI: Amanda Dillard, PhD

    Two experiments examine the effects of tailored testimonials on people's knowledge, satisfaction, interest in shared decision-making, and behavioral intentions after reading a colorectal cancer screening decision aid. (09/01/2007 - 08/31/2008)

  • Breast Cancer Genetics Network Website Improvements

    PI: J. Scott Roberts, PhD

    This study refines an existing Web-based, tailored decision aid for women at risk for breast and ovarian cancer. The existing educational materials are made more interactive, more highly tailored and personalized. (09/01/2007 - 08/31/2008)

  • SCanIT

    PI: Masahito Jimbo, MD, PhD, MPH

    Streamlining Cancer Screening Decision through Information Technology (SCanIT) aims to use information technology to link colorectal cancer (CRC) screening with health services at an integrated health system. The goal is to enhance informed decision making (IDM) for the patient and shared decision-making (SDM) between the patient and the physician. (05/01/2007 - 04/30/2008)

  • Decider Guider

    PI: Sarah T. Hawley, PhD, MPH

    This study translates a paper-based preference-screening tool into a web-based preference-tailored intervention that is effective for increasing informed decision making (IDM) and compliance with colorectal cancer (CRC) screening. The computer-based preference tool is used in clinical settings to help low-risk individuals decide which of five CRC screening tests best fits their preferences. By helping them choose which test to take, we hope to increase CRC screening rates. (01/02/2006 - 08/31/2007)

    Related Media:

  • CSATS

    PI: Masahito Jimbo, MD, PhD, MPH

    Cancer Screening Adherence through Technology-Enhanced Shared Decision Making (CSATS) is a tailored behavioral intervention to improve patient adherence to colorectal cancer screening (CRC). CSATS links a computerized screening prompt/reminder system with a tailored behavioral intervention. The intervention combines a screening decision aid with a risk assessment. Upon completion of the intervention, a recommendation is provided to both patient and physician to enhance shared decision making between the two. (01/02/2006 - 08/31/2007)

  • REACH

    PI: Susan D. Goold, MD, MHSA, MA

    REACH is a variation of the existing CHAT software CD to make the simulation survey cover a broader range of benefit options beyond health care. (01/01/2005 - 02/28/2005)

  • CECCR - Center of Excellence in Cancer Communications Research

    PI: Victor J. Strecher, PhD, MPH

    The purpose of the University of Michigan Center of Excellence in Cancer Communications Research (CECCR) is to develop an efficient, theory-driven model for generating tailored health behavior interventions that is generalizable across health behaviors and socio-demographic populations. (09/01/2003 - 08/31/2008)

  • Guide to Decide

    PI: Victor J. Strecher, PhD, MPH , Angela Fagerlin, PhD , Peter A. Ubel, MD

    Guide to Decide uses a multi-phased experimental process to explore methods of communicating risk regarding tamoxifen or raloxifene prophylaxis to women at high risk for breast cancer. (07/01/2003 - 08/31/2008)

  • Making the Choice - Audio and Internet

    PI: John T. Wei, MD, MS

    This project is an adaptation of Making the Choice. We revise the paper-based decision aid and develop alternative media formats (audiotape- and Internet-based versions) of the paper based decision aid to increase distribution and utilization. We also test the paper, audiotape, and Internet-based decision aids in an appropriate population of patients to provide pilot data on the tools' efficacy for improving patient knowledge. (09/30/2002 - 09/29/2004)

  • Making the Choice

    PI: John T. Wei, MD, MS

    Making the Choice is a booklet to help men better understand prostate health and the issues surrounding prostate cancer testing. (09/30/2002 - 09/29/2004)

  • Coloweb II (Katz)

    PI: Steven J. Katz, MD, MPH

    This project builds on the original ColoWeb project, including updates to content and surveys, and delivering the intervention and surveys to 1,200 patients. (01/01/2002 - 09/30/2003)

  • coloWeb (Ruffin)

    PI: Mack T. Ruffin IV, MD, MPH

    This study tests the efficacy of a multimedia decision aid that addresses the facts and myths about colorectal cancer, identifies the risk factors for colorectal cancer, and reviews the options for colorectal screening. Work for the development on this web-based decision aid is based on results from the coloWeb (Katz) project. (10/01/2000 - 09/30/2003)

  • coloWeb (Katz)

    PI: Steven J. Katz, MD, MPH

    This project focuses on development of a tailored web-based program that allows patients to receive individually tailored information about colorectal screening initiatives. The program is evaluated in a randomized controlled trial at three primary care clinics. This project combines efforts with coloWeb (Ruffin) to complete both focus groups and a pilot test of the tailored program. (10/01/2000 - 09/30/2001)

    Related Media:

  • Cancer and Genetics

    PI: Sofia D. Merajver, MD, PhD

    Due to the complexity of information surrounding BRCA1/2 counseling and testing and its time consuming nature, efforts to facilitate the genetic counseling and education process are needed. This project aims to develop a flip book, CD-ROM, and website for use by genetics counselors with their patients covering the topics: basic genetics, cancer and genetics, genes associated with breast cancer, genetics testing, and managing cancer risk. (04/01/1997 - 07/30/1998)

  • Prostate Cancer Decision-Making

    PI: Robert C. Burack, MD, MPH

    This project is focused on creating a booklet to help men better understand prostate health and the issues surrounding prostate cancer testing. (09/01/1996 - 10/31/1997)

  • I Can Decide Dashboard

    New

    PI: Lawrence C. An, MD , Sarah T. Hawley, PhD, MPH

    Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoreginal and systemic treatment. Currently many of these decisions do not meet the definition of a high quality decision, defined as one that is both informed (based on an accurate understanding of the treatment risks and benefits) and preference-concordant (consistent with the patient's underlying preferences). I Can Decide evaluates the impact of an innovative decision tool on locoregional and systemic therapy decision making for newly diagnosed breast cancer patients.  The I Can Decide Dashboard links the I Can Decide patient website to a clinic dashboard. Some of the information patients enter on the website will be shared with the clinic. The goal is to improve communication and help patients make informed treatment decisions. (08/31/2017)